2005
DOI: 10.1161/circulationaha.104.500447
|View full text |Cite
|
Sign up to set email alerts
|

Transplantation of Mesenchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy

Abstract: Background-Pluripotent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

23
449
2
7

Year Published

2007
2007
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 604 publications
(484 citation statements)
references
References 55 publications
23
449
2
7
Order By: Relevance
“…Furthermore transplanted MSCs improved cardiac function in dilated cardiomyopathy (26). For that reason, we speculated that MSCs may differentiate into multiple skin cell types during wound healing.…”
Section: Mscs Differentiate Into Multiple Skin Cell Typesmentioning
confidence: 97%
“…Furthermore transplanted MSCs improved cardiac function in dilated cardiomyopathy (26). For that reason, we speculated that MSCs may differentiate into multiple skin cell types during wound healing.…”
Section: Mscs Differentiate Into Multiple Skin Cell Typesmentioning
confidence: 97%
“…First promising results for stem cell therapy in nonischemic dilated cardiomyopathy (DCM) were reported by Nagaya et al (120). The aim of the study was to investigate whether transplanted mesenchymal stem cells (MSCs) induce myogenesis and angiogenesis in a rat model of DCM.…”
Section: Dilated Cardiomyopathymentioning
confidence: 99%
“…Furthermore, the accessibility, ease of handling, and enormous expansion potential of MSCs, together with their capacity for self-renewal and amenability to allogenic transplantation (Amado et al, 2005;Dai et al, 2005), provide a nearly unlimited supply of cells for therapeutic applications. The effect of MSCs is thought to be mediated by secreting a number of cardio-protective cytokines and growth factors in addition to differentiation (Kinnaird et al, 2004a(Kinnaird et al, , 2004bNagaya et al, 2005). Despite initial optimism, MSC transplant therapy has been stymied by the low cellular survival rate after transplantation in the first few days (Toma et al, 2002).…”
Section: Introductionmentioning
confidence: 99%